The price of SPOK is predicted to go up -7.52%, based on the high correlation periods with NCLH. The similarity of these two price pattern on the periods is 95.18%.
SPOK
NCLH
Down: -7.52%Similarity: 95.18%
SPOK Revenue Forecast
SPOK EPS Forecast
SPOK FAQs
What is bull’s view on SPOK?
SPOK stock closed at $16.08 on January 31, 2025, with a slight decline of 0.19%. Bulls view the stock positively due to its debt-free status, stable recurring revenue from healthcare clients, and recent software bookings growth of 10.3% quarter-over-quarter. However, its current price of $16.05 reflects limited short-term upside unless further catalysts emerge.
What is bear's view on SPOK?
SPOK stock closed at $16.08 on January 31, 2025, down 0.19%. Bearish sentiment arises from declining revenues in both Wireless and Software segments, with Q2 2024 revenue down 6.8% year-over-year to $33.9M. Despite stable cash reserves, challenges like shrinking gross margins and prolonged sales cycles weigh on its outlook.
What is SPOK revenue forecast for next quarter?
The market consensus for SPOK's revenue in the upcoming quarter is projected to be approximately $34.9M USD.
B. Riley analyst Kyle Bauser last night initiated coverage of Spok with a Neutral rating and $15 price target. Spok is a healthcare IT company that provides communications capabilities to leading hospitals in the U.S., the analyst tells investors in a research note. The firm says that if the company were to return to adjusted EBITDA growth as a result of reduced pager erosion, higher software sales growth, and international expansion, it would likely become more constructive on the name. now, Riley awaits margin expansion and remains on the sidelines.